Published in Zentralbl Gynakol on October 21, 1972
Total synthesis of (+)-amphidinolide K. J Am Chem Soc (2001) 1.15
Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem Biol Interact (2001) 1.01
Nucleotide sequence of a 16S rRNA gene from Anabaena sp. strain PCC 7120. Nucleic Acids Res (1991) 0.99
Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis (1997) 0.97
Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene. Environ Mol Mutagen (1995) 0.80
Palladium-induced cyclizations for the synthesis of cis-2,5-disubstituted-3-methylenetetrahydrofurans: studies of the C7-C22 core of amphidinolide K. Org Lett (1999) 0.79
Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis (1997) 0.79
Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure. Environ Mol Mutagen (1996) 0.78
[Conization and pregnancy--an analysis of various therapeutic measures for the prevention of premature labor]. Zentralbl Gynakol (1991) 0.78
[Changes in the vaginal flora caused by supporting pessary treatment in pregnancy]. Zentralbl Gynakol (1983) 0.78
Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat Res (1997) 0.78
The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene. Mutat Res (1998) 0.77
[Early and late results after surgical treatment of genital descensus and prolapse]. Zentralbl Gynakol (1974) 0.75
[Results of an extensive thrombosis prevention in pregnancy]. Zentralbl Gynakol (1972) 0.75
[The clinical relevance of the SPHA test for the demonstration of IgM in syphilis diagnosis. Report on 3 years' experiences]. Dermatol Monatsschr (1984) 0.75
[Comparative colposcopic, cytological and histological studies of the uterine cervix during pregnancy]. Zentralbl Gynakol (1976) 0.75
[A cubical support pessary within the scope of complex therapy of threatening prematurity]. Zentralbl Gynakol (1978) 0.75
[Modification of the rate of low birth-weight infants by using a prematurity and dysmaturity program]. Z Arztl Fortbild (Jena) (1982) 0.75
[Case report on cervix changes in pregnancy]. Zentralbl Gynakol (1970) 0.75
[Diagnostic errors. Diagnosis on admission: rheumatic fever, clinical diagnosis: acute syphilitic polyarthritis]. Dtsch Gesundheitsw (1972) 0.75
[Recognition, theerapy and course of pregnancy in patients with jheart disease]. Zentralbl Gynakol (1968) 0.75
[C-type-like particles in normal human placentas (author's transl)]. Arch Geschwulstforsch (1975) 0.75
Mobile coronary care unit. J Iowa Med Soc (1979) 0.75
[Diagnosis and therapy of a case of congenital hydrothorax caused by extralobar lung separation]. Kinderarztl Prax (1987) 0.75
[Medical evaluation and rehabilitation following intensive therapy of malignomas in the female genitalia and breast]. Zentralbl Gynakol (1975) 0.75
[On early tooth eruption]. Zentralbl Gynakol (1967) 0.75
[Clinical experiences with percutaneous digitoxin therapy in pregnant women with varicose veins]. Zentralbl Gynakol (1976) 0.75
[Heart diseases associated with pregnancy and labor]. Zentralbl Gynakol (1970) 0.75
[Modification of the rate of complications in the inflammatory adnexa process and pregnancy interruption]. Zentralbl Gynakol (1977) 0.75
[Adverse effects of radical vaginal surgery and radiotherapy on ureteral function, their prevention and therapy]. Z Arztl Fortbild (Jena) (1973) 0.75
[Experience with nuclear medical placenta perfusion diagnosis]. Zentralbl Gynakol (1979) 0.75
[The solid-phase hemadsorption (SPHA) test in syphilis reinfection]. Z Hautkr (1984) 0.75
[Conservative treatment of descensus and genital prolapse by means of pessaries from permanent-soft plastic]. Zentralbl Gynakol (1976) 0.75
Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene. Mutat Res (2001) 0.75